FM 140 vs FM100 Study in Patients With Multiple Myeloma

NCT00505895 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Melphalan
DRUG: Fludarabine
PROCEDURE: Stem Cell Infusion
DRUG: Rituximab

Sponsor

M.D. Anderson Cancer Center